Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2010-05-20 12:52:41 UTC |
---|
Update Date | 2022-03-07 02:51:34 UTC |
---|
HMDB ID | HMDB0013626 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Adrenoyl ethanolamide |
---|
Description | Adrenoyl ethanolamide is a N-acylethanolamine. N-acylethanolamines (NAEs) constitute a class of lipid compounds naturally present in both animal and plant membranes as constituents of the membrane-bound phospholipid, N-acylphosphatidylethanolamine (NAPE). NAPE is composed of a third fatty acid moiety linked to the amino head group of the commonly occurring membrane phospholipid, phosphatidylethanolamine. NAEs are released from NAPE by phospholipase D-type hydrolases in response to a variety of stimuli. Transient NAE release and accumulation has been attributed a variety of biological activities, including neurotransmission, membrane protection, and immunomodulation in animals. N-oleoylethanolamine is an inhibitor of the sphingolipid signaling pathway, via specific ceramidase inhibition (ceramidase converts ceramide to sphingosine). N-oleoylethanolamine blocks the effects of TNF- and arachidonic acid on intracellular Ca concentration. (PMID: 12692337 , 12056855 , 12560208 , 11997249 ). |
---|
Structure | CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(=O)NCCO InChI=1S/C24H41NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-24(27)25-22-23-26/h6-7,9-10,12-13,15-16,26H,2-5,8,11,14,17-23H2,1H3,(H,25,27)/b7-6-,10-9-,13-12-,16-15- |
---|
Synonyms | Value | Source |
---|
N-(7Z,10Z,13Z,16Z-Docosatetraenoyl)-ethanolamine | Kegg | 7,10,13,16-DTEA | MeSH | 7,10,13,16-Docosatetraenylethanolamide | MeSH | N-(7Z,10Z,13Z,16Z-Docosatetraenoyl)-ethanolamide | KEGG, HMDB | 7,10,13,16-Docosatetraenoylethanolamine | HMDB | 8,11,14-Eicosatrienoylethanolamide | HMDB | Adrenoyl-ethanolamine | HMDB | DEA | HMDB | Docosa-7,10,13,16-tetraenoate | HMDB | Docosa-7,10,13,16-tetraenoic acid | HMDB | Docosa-7,10,13,16-tetraenoic acid (2-hydroxy-ethyl)-amide | HMDB | N-(8Z,11Z,14Z-Icosatrienoyl)-ethanolamide | HMDB |
|
---|
Chemical Formula | C24H41NO2 |
---|
Average Molecular Weight | 375.5878 |
---|
Monoisotopic Molecular Weight | 375.313729561 |
---|
IUPAC Name | (7Z,10Z,13Z,16Z)-N-(2-hydroxyethyl)docosa-7,10,13,16-tetraenamide |
---|
Traditional Name | docosatetraenoylethanolamide |
---|
CAS Registry Number | 150314-35-5 |
---|
SMILES | CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(=O)NCCO |
---|
InChI Identifier | InChI=1S/C24H41NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-24(27)25-22-23-26/h6-7,9-10,12-13,15-16,26H,2-5,8,11,14,17-23H2,1H3,(H,25,27)/b7-6-,10-9-,13-12-,16-15- |
---|
InChI Key | FMVHVRYFQIXOAF-DOFZRALJSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as n-acylethanolamines. N-acylethanolamines are compounds containing an N-acyethanolamine moiety, which is characterized by an acyl group is linked to the nitrogen atom of ethanolamine. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic nitrogen compounds |
---|
Class | Organonitrogen compounds |
---|
Sub Class | Amines |
---|
Direct Parent | N-acylethanolamines |
---|
Alternative Parents | |
---|
Substituents | - N-acylethanolamine
- Fatty amide
- N-acyl-amine
- Fatty acyl
- Carboxamide group
- Secondary carboxylic acid amide
- Carboxylic acid derivative
- Alcohol
- Organooxygen compound
- Primary alcohol
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Carbonyl group
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Adrenoyl ethanolamide,1TMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)NCCO[Si](C)(C)C | 3070.9 | Semi standard non polar | 33892256 | Adrenoyl ethanolamide,1TMS,isomer #2 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)N(CCO)[Si](C)(C)C | 3009.1 | Semi standard non polar | 33892256 | Adrenoyl ethanolamide,2TMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)N(CCO[Si](C)(C)C)[Si](C)(C)C | 3054.6 | Semi standard non polar | 33892256 | Adrenoyl ethanolamide,2TMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)N(CCO[Si](C)(C)C)[Si](C)(C)C | 3091.0 | Standard non polar | 33892256 | Adrenoyl ethanolamide,2TMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)N(CCO[Si](C)(C)C)[Si](C)(C)C | 3050.0 | Standard polar | 33892256 | Adrenoyl ethanolamide,1TBDMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)NCCO[Si](C)(C)C(C)(C)C | 3315.3 | Semi standard non polar | 33892256 | Adrenoyl ethanolamide,1TBDMS,isomer #2 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)N(CCO)[Si](C)(C)C(C)(C)C | 3259.3 | Semi standard non polar | 33892256 | Adrenoyl ethanolamide,2TBDMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)N(CCO[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3552.6 | Semi standard non polar | 33892256 | Adrenoyl ethanolamide,2TBDMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)N(CCO[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3428.7 | Standard non polar | 33892256 | Adrenoyl ethanolamide,2TBDMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)N(CCO[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3098.4 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Adrenoyl ethanolamide GC-MS (Non-derivatized) - 70eV, Positive | splash10-014l-8596000000-fb56397a219ca27323ee | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Adrenoyl ethanolamide GC-MS (1 TMS) - 70eV, Positive | splash10-00yi-9263400000-08ff1e6d3a4de7602967 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Adrenoyl ethanolamide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Adrenoyl ethanolamide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adrenoyl ethanolamide 10V, Positive-QTOF | splash10-01t9-4019000000-af6365155318609eed17 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adrenoyl ethanolamide 20V, Positive-QTOF | splash10-03dl-9122000000-8e28d155f14c7badafed | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adrenoyl ethanolamide 40V, Positive-QTOF | splash10-03di-9130000000-e57644d2630bb1b3b060 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adrenoyl ethanolamide 10V, Negative-QTOF | splash10-00di-0009000000-7ec4d3341aea6c7e0b11 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adrenoyl ethanolamide 20V, Negative-QTOF | splash10-074l-5009000000-00b3c02e8e16ba5c1e65 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adrenoyl ethanolamide 40V, Negative-QTOF | splash10-0006-9011000000-d5cb6f4617816a6a0fb2 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adrenoyl ethanolamide 10V, Negative-QTOF | splash10-00di-0009000000-19586eb33dc1d3f7d937 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adrenoyl ethanolamide 20V, Negative-QTOF | splash10-00di-4119000000-9b6fce221585710cf9dc | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adrenoyl ethanolamide 40V, Negative-QTOF | splash10-052f-9002000000-b09284232013b6fc7b7a | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adrenoyl ethanolamide 10V, Positive-QTOF | splash10-01t9-8119000000-da9fd03d8d325045c6d7 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adrenoyl ethanolamide 20V, Positive-QTOF | splash10-03dl-9000000000-7ae2abc24b2249be27a2 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adrenoyl ethanolamide 40V, Positive-QTOF | splash10-03dl-9100000000-60701a0404a7efc4eea6 | 2021-09-25 | Wishart Lab | View Spectrum |
|
---|
General References | - Hofmann U, Domeier E, Frantz S, Laser M, Weckler B, Kuhlencordt P, Heuer S, Keweloh B, Ertl G, Bonz AW: Increased myocardial oxygen consumption by TNF-alpha is mediated by a sphingosine signaling pathway. Am J Physiol Heart Circ Physiol. 2003 Jun;284(6):H2100-5. Epub 2003 Jan 30. [PubMed:12560208 ]
- Tripathy S, Kleppinger-Sparace K, Dixon RA, Chapman KD: N-acylethanolamine signaling in tobacco is mediated by a membrane-associated, high-affinity binding protein. Plant Physiol. 2003 Apr;131(4):1781-91. [PubMed:12692337 ]
- Lecour S, Smith RM, Woodward B, Opie LH, Rochette L, Sack MN: Identification of a novel role for sphingolipid signaling in TNF alpha and ischemic preconditioning mediated cardioprotection. J Mol Cell Cardiol. 2002 May;34(5):509-18. [PubMed:12056855 ]
- Amadou A, Nawrocki A, Best-Belpomme M, Pavoine C, Pecker F: Arachidonic acid mediates dual effect of TNF-alpha on Ca2+ transients and contraction of adult rat cardiomyocytes. Am J Physiol Cell Physiol. 2002 Jun;282(6):C1339-47. [PubMed:11997249 ]
|
---|